Hotline: +86-18022463983    020-85206863

United States Ziprasidone Market Report & Forecast 2021-2027

Published Date: 2021-10-07   |   Pages: 92   |   Tables: 103   |  Pharma & Healthcare

This report contains market size and forecasts of Ziprasidone in United States, including the following market information:

United States Ziprasidone Market Revenue, 2016-2021, 2022-2027, ($ millions)

United States Ziprasidone Market Sales, 2016-2021, 2022-2027, (K Units)

United States top five Ziprasidone companies in 2020 (%)

The global Ziprasidone market size is expected to growth from US$ XX million in 2020 to US$ XX million by 2027; it is expected to grow at a CAGR of XX% during 2021-2027.

The United States Ziprasidone market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.

QYResearch has surveyed the Ziprasidone manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

United States Ziprasidone Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)

United States Ziprasidone Market Segment Percentages, By Type, 2020 (%)

Oral Capsule

Injection

United States Ziprasidone Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)

United States Ziprasidone Market Segment Percentages, By Application, 2020 (%)

Hospital

Drug Store

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Ziprasidone revenues in United States market, 2016-2021 (Estimated), ($ millions)

Key companies Ziprasidone revenues share in United States market, 2020 (%)

Key companies Ziprasidone sales in United States market, 2016-2021 (Estimated), (K Units)

Key companies Ziprasidone sales share in United States market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

Pfizer

Sandoz

Lupin Pharmaceuticals

Mylan Pharmaceuticals

Apotex

Dr. Reddy's Laboratories

Wockhardt

Aurobindo

Macleods Pharmaceuticals

Zydus Pharmaceuticals

Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:


Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

 

Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

 

Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

 

Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

 

Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

 

1 Introduction to Research & Analysis Reports

1.1 Ziprasidone Market Definition

1.2 Market Segments

1.2.1 Segment by Type

1.2.2 Segment by Application

1.3 United States Ziprasidone Market Overview

1.4 Methodology & Sources of Information

1.4.1 Research Methodology

1.4.2 Research Process

1.4.3 Base Year

2 United States Ziprasidone Overall Market Size

2.1 United States Ziprasidone Market Size: 2021 VS 2027

2.2 United States Ziprasidone Revenue, Prospects & Forecasts: 2016-2027

2.3 United States Ziprasidone Sales: 2016-2027

3 Company Landscape

3.1 Top Ziprasidone Players in United States Market

3.2 Top United States Ziprasidone Companies Ranked by Revenue

3.3 United States Ziprasidone Revenue by Companies

3.4 United States Ziprasidone Sales by Companies

3.5 United States Ziprasidone Price by Manufacturer (2016-2021)

3.6 Top 3 and Top 5 Ziprasidone Companies in United States Market, by Revenue in 2020

3.7 Manufacturers Ziprasidone Product Type

3.8 Tier 1, Tier 2 and Tier 3 Ziprasidone Players in United States Market

3.8.1 List of Tier 1 Ziprasidone Companies in United States

3.8.2 List of Tier 2 and Tier 3 Ziprasidone Companies in United States

4 Sights by Type

4.1 Overview

4.1.1 By Type - United States Ziprasidone Market Size Markets, 2021 & 2027

4.1.2 Oral Capsule

4.1.3 Injection

4.2 By Type - United States Ziprasidone Revenue & Forecasts

4.2.1 By Type - United States Ziprasidone Revenue, 2016-2021

4.2.2 By Type - United States Ziprasidone Revenue, 2022-2027

4.2.3 By Type - United States Ziprasidone Revenue Market Share, 2016-2027

4.3 By Type - United States Ziprasidone Sales & Forecasts

4.3.1 By Type - United States Ziprasidone Sales, 2016-2021

4.3.2 By Type - United States Ziprasidone Sales, 2022-2027

4.3.3 By Type - United States Ziprasidone Sales Market Share, 2016-2027

4.4 By Type - United States Ziprasidone Price (Manufacturers Selling Prices), 2016-2027

5 Sights by Application

5.1 Overview

5.1.1 By Application - United States Ziprasidone Market Size, 2021 & 2027

5.1.2 Hospital

5.1.3 Drug Store

5.2 By Application - United States Ziprasidone Revenue & Forecasts

5.2.1 By Application - United States Ziprasidone Revenue, 2016-2021

5.2.2 By Application - United States Ziprasidone Revenue, 2022-2027

5.2.3 By Application - United States Ziprasidone Revenue Market Share, 2016-2027

5.3 By Application - United States Ziprasidone Sales & Forecasts

5.3.1 By Application - United States Ziprasidone Sales, 2016-2021

5.3.2 By Application - United States Ziprasidone Sales, 2022-2027

5.3.3 By Application - United States Ziprasidone Sales Market Share, 2016-2027

5.4 By Application - United States Ziprasidone Price (Manufacturers Selling Prices), 2016-2027

6 Manufacturers & Brands Profiles

6.1 Pfizer

6.1.1 Pfizer Corporation Information

6.1.2 Pfizer Overview

6.1.3 Pfizer Ziprasidone Sales and Revenue in United States Market (2016-2021)

6.1.4 Pfizer Ziprasidone Product Description

6.1.5 Pfizer Recent Developments

6.2 Sandoz

6.2.1 Sandoz Corporation Information

6.2.2 Sandoz Overview

6.2.3 Sandoz Ziprasidone Sales and Revenue in United States Market (2016-2021)

6.2.4 Sandoz Ziprasidone Product Description

6.2.5 Sandoz Recent Developments

6.3 Lupin Pharmaceuticals

6.3.1 Lupin Pharmaceuticals Corporation Information

6.3.2 Lupin Pharmaceuticals Overview

6.3.3 Lupin Pharmaceuticals Ziprasidone Sales and Revenue in United States Market (2016-2021)

6.3.4 Lupin Pharmaceuticals Ziprasidone Product Description

6.3.5 Lupin Pharmaceuticals Recent Developments

6.4 Mylan Pharmaceuticals

6.4.1 Mylan Pharmaceuticals Corporation Information

6.4.2 Mylan Pharmaceuticals Overview

6.4.3 Mylan Pharmaceuticals Ziprasidone Sales and Revenue in United States Market (2016-2021)

6.4.4 Mylan Pharmaceuticals Ziprasidone Product Description

6.4.5 Mylan Pharmaceuticals Recent Developments

6.5 Apotex

6.5.1 Apotex Corporation Information

6.5.2 Apotex Overview

6.5.3 Apotex Ziprasidone Sales and Revenue in United States Market (2016-2021)

6.5.4 Apotex Ziprasidone Product Description

6.5.5 Apotex Recent Developments

6.6 Dr. Reddy's Laboratories

6.6.1 Dr. Reddy's Laboratories Corporation Information

6.6.2 Dr. Reddy's Laboratories Overview

6.6.3 Dr. Reddy's Laboratories Ziprasidone Sales and Revenue in United States Market (2016-2021)

6.6.4 Dr. Reddy's Laboratories Ziprasidone Product Description

6.6.5 Dr. Reddy's Laboratories Recent Developments

6.7 Wockhardt

6.7.1 Wockhardt Corporation Information

6.7.2 Wockhardt Overview

6.7.3 Wockhardt Ziprasidone Sales and Revenue in United States Market (2016-2021)

6.7.4 Wockhardt Ziprasidone Product Description

6.7.5 Wockhardt Recent Developments

6.8 Aurobindo

6.8.1 Aurobindo Corporation Information

6.8.2 Aurobindo Overview

6.8.3 Aurobindo Ziprasidone Sales and Revenue in United States Market (2016-2021)

6.8.4 Aurobindo Ziprasidone Product Description

6.8.5 Aurobindo Recent Developments

6.9 Macleods Pharmaceuticals

6.9.1 Macleods Pharmaceuticals Corporation Information

6.9.2 Macleods Pharmaceuticals Overview

6.9.3 Macleods Pharmaceuticals Ziprasidone Sales and Revenue in United States Market (2016-2021)

6.9.4 Macleods Pharmaceuticals Ziprasidone Product Description

6.9.5 Macleods Pharmaceuticals Recent Developments

6.10 Zydus Pharmaceuticals

6.10.1 Zydus Pharmaceuticals Corporation Information

6.10.2 Zydus Pharmaceuticals Overview

6.10.3 Zydus Pharmaceuticals Ziprasidone Sales and Revenue in United States Market (2016-2021)

6.10.4 Zydus Pharmaceuticals Ziprasidone Product Description

6.10.5 Zydus Pharmaceuticals Recent Developments

7 United States Ziprasidone Production Capacity, Analysis

7.1 United States Ziprasidone Production Capacity, 2016-2027

7.2 Ziprasidone Production Capacity of Key Manufacturers in United States Market

8 Key Market Trends, Opportunity, Drivers and Restraints

8.1 Market Opportunities & Trends

8.2 Market Drivers

8.3 Market Restraints

9 Ziprasidone Supply Chain Analysis

9.1 Ziprasidone Industry Value Chain

9.2 Ziprasidone Upstream Market

9.3 Ziprasidone Downstream and Clients

9.4 Marketing Channels Analysis

9.4.1 Marketing Channels

9.4.2 Ziprasidone Distributors and Sales Agents in United States Market

10 Conclusion

11 Appendix

11.1 Note

11.2 Examples of Clients

11.3 Author Details

11.4 Disclaimer

List of Tables

Table 1. Key Players of Ziprasidone in United States Market

Table 2. Top Ziprasidone Players in United States Market, Ranking by Revenue (2019)

Table 3. United States Ziprasidone Revenue by Companies, (US$, Mn), 2016-2021

Table 4. United States Ziprasidone Revenue Share by Companies, 2016-2021

Table 5. United States Ziprasidone Sales by Companies, (K Units), 2016-2021

Table 6. United States Ziprasidone Sales Share by Companies, 2016-2021

Table 7. Key Manufacturers Ziprasidone Price (2016-2021) & (USD/Unit)

Table 8. Manufacturers Ziprasidone Product Type

Table 9. List of Tier 1 Ziprasidone Companies, Revenue (US$, Mn) in 2020 and Market Share

Table 10. List of Tier 2 and Tier 3 Ziprasidone Companies, Revenue (US$, Mn) in 2020 and Market Share

Table 11. Major Manufacturers of Oral Capsule

Table 12. Major Manufacturers of Injection

Table 13. By Type – United States Ziprasidone Revenue, (US$, Mn), 2021 & 2027

Table 14. By Type - United States Ziprasidone Revenue (US$, Mn), 2016-2021

Table 15. By Type - United States Ziprasidone Revenue (US$, Mn), 2022-2027

Table 16. By Type - United States Ziprasidone Sales (K Units), 2016-2021

Table 17. By Type - United States Ziprasidone Sales (K Units), 2022-2027

Table 18. By Application – United States Ziprasidone Revenue, (US$, Mn), 2021 VS 2027

Table 19. By Application - United States Ziprasidone Revenue (US$, Mn), 2016-2021

Table 20. By Application - United States Ziprasidone Revenue (US$, Mn), 2022-2027

Table 21. By Application - United States Ziprasidone Sales (K Units), 2016-2021

Table 22. By Application - United States Ziprasidone Sales (K Units), 2022-2027

Table 23. Pfizer Corporation Information

Table 24. Pfizer Description and Major Businesses

Table 25. Pfizer Ziprasidone Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

Table 26. Pfizer Ziprasidone Product

Table 27. Pfizer Recent Developments

Table 28. Sandoz Corporation Information

Table 29. Sandoz Description and Major Businesses

Table 30. Sandoz Ziprasidone Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

Table 31. Sandoz Ziprasidone Product

Table 32. Sandoz Recent Developments

Table 33. Lupin Pharmaceuticals Corporation Information

Table 34. Lupin Pharmaceuticals Description and Major Businesses

Table 35. Lupin Pharmaceuticals Ziprasidone Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

Table 36. Lupin Pharmaceuticals Ziprasidone Product

Table 37. Lupin Pharmaceuticals Recent Developments

Table 38. Mylan Pharmaceuticals Corporation Information

Table 39. Mylan Pharmaceuticals Description and Major Businesses

Table 40. Mylan Pharmaceuticals Ziprasidone Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

Table 41. Mylan Pharmaceuticals Ziprasidone Product

Table 42. Mylan Pharmaceuticals Recent Developments

Table 43. Apotex Corporation Information

Table 44. Apotex Description and Major Businesses

Table 45. Apotex Ziprasidone Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

Table 46. Apotex Ziprasidone Product

Table 47. Apotex Recent Developments

Table 48. Dr. Reddy's Laboratories Corporation Information

Table 49. Dr. Reddy's Laboratories Description and Major Businesses

Table 50. Dr. Reddy's Laboratories Ziprasidone Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

Table 51. Dr. Reddy's Laboratories Ziprasidone Product

Table 52. Dr. Reddy's Laboratories Recent Developments

Table 53. Wockhardt Corporation Information

Table 54. Wockhardt Description and Major Businesses

Table 55. Wockhardt Ziprasidone Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

Table 56. Wockhardt Ziprasidone Product

Table 57. Wockhardt Recent Developments

Table 58. Aurobindo Corporation Information

Table 59. Aurobindo Description and Major Businesses

Table 60. Aurobindo Ziprasidone Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

Table 61. Aurobindo Ziprasidone Product

Table 62. Aurobindo Recent Developments

Table 63. Macleods Pharmaceuticals Corporation Information

Table 64. Macleods Pharmaceuticals Description and Major Businesses

Table 65. Macleods Pharmaceuticals Ziprasidone Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

Table 66. Macleods Pharmaceuticals Ziprasidone Product

Table 67. Macleods Pharmaceuticals Recent Developments

Table 68. Zydus Pharmaceuticals Corporation Information

Table 69. Zydus Pharmaceuticals Description and Major Businesses

Table 70. Zydus Pharmaceuticals Ziprasidone Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

Table 71. Zydus Pharmaceuticals Ziprasidone Product

Table 72. Zydus Pharmaceuticals Recent Developments

Table 73. Ziprasidone Production Capacity (K Units) of Key Manufacturers in United States Market, 2019-2021 (K Units)

Table 74. United States Ziprasidone Capacity Market Share of Key Manufacturers, 2019-2021

Table 75. Ziprasidone Market Opportunities & Trends in United States Market

Table 76. Ziprasidone Market Drivers in United States Market

Table 77. Ziprasidone Market Restraints in United States Market

Table 78. Ziprasidone Raw Materials

Table 79. Ziprasidone Raw Materials Suppliers in United States Market

Table 80. Typical Ziprasidone Downstream

Table 81. Ziprasidone Downstream Clients in United States Market

Table 82. Ziprasidone Distributors and Sales Agents in United States Market

List of Figures

Figure 1. Ziprasidone Product Picture

Figure 2. Ziprasidone Segment by Type

Figure 3. Ziprasidone Segment by Application

Figure 4. United States Ziprasidone Market Overview: 2020

Figure 5. United States Ziprasidone Market Size: 2021 VS 2027 (US$, Mn)

Figure 6. United States Ziprasidone Revenue, 2016-2027 (US$, Mn)

Figure 7. Ziprasidone Sales in United States Market: 2016-2027 (K Units)

Figure 8. The Top 3 and 5 Players Market Share by Ziprasidone Revenue in 2020

Figure 9. Oral Capsule Product Picture

Figure 10. Injection Product Picture

Figure 11. By Type - United States Ziprasidone Sales Market Share, 2016-2027

Figure 12. By Type - United States Ziprasidone Revenue Market Share, 2016-2027

Figure 13. By Type - United States Ziprasidone Price (USD/Unit), 2016-2027

Figure 14. Hospital

Figure 15. Drug Store

Figure 16. By Application - United States Ziprasidone Sales Market Share, 2016-2027

Figure 17. By Application - United States Ziprasidone Revenue Market Share, 2016-2027

Figure 18. By Application - United States Ziprasidone Price (USD/Unit), 2016-2027

Figure 19. Pfizer Ziprasidone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 20. Sandoz Ziprasidone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 21. Lupin Pharmaceuticals Ziprasidone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 22. Mylan Pharmaceuticals Ziprasidone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 23. Apotex Ziprasidone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 24. Dr. Reddy's Laboratories Ziprasidone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 25. Wockhardt Ziprasidone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 26. Aurobindo Ziprasidone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 27. Macleods Pharmaceuticals Ziprasidone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 28. Zydus Pharmaceuticals Ziprasidone Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 29. United States Ziprasidone Production Capacity (K Units), 2016-2027

Figure 30. Ziprasidone Industry Value Chain

Figure 31. Marketing Channels

Our Clients